News
LigoLab Offers Direct-to-Consumer Lab Testing Support for Provider Insurance Discovery & Eligibility Checks
October 16, 2024
LOS ANGELES, CA - TestDirectly, a direct-to-consumer lab testing portal developed by LigoLab Information Systems, developers of enterprise grade pathology management software, now supports provider insurance discovery and insurance eligibility checks. This newly added auto-check verification feature is designed to give laboratory providers much more laboratory revenue cycle management (lab RCM, lab billing) success by giving them the ability to verify a patient’s active insurance coverage and eligibility before accepting an online order and processing a lab test via TestDirectly (TestDirectly.com).
Learn More: The Power of Integration: Unleashing the Potential of LigoLab's LIS System & Lab RCM Platform
The cloud-based and user-friendly direct-to-consumer lab testing portal easily integrates with all laboratory information systems (LIS systems, LIS software) and laboratory billing solutions with a typical deployment measured in weeks rather than months. Once implemented, TestDirectly results eliminate paper forms and bottlenecks with advanced automation that supports turn-key point-of-care digital lab workflow for patients and testing providers, connecting them for convenient direct-to-consumer lab testing such as COVID-19, sexually transmitted infections, urinary tract infections, allergies, genetic screenings, and more.
From test ordering to specimen collection, sample tracking, and processing, the creation and delivery of reports, the management of payment and compliance, and state registry reporting, the TestDirectly portal is a pathology lab software that delivers a better experience for all stakeholders and gives patients increased access and control over their healthcare.
Learn More: Best Pathology Lab Reporting Software - Buyers Guide and Checklist
TestDirectly is a direct-to-consumer lab testing solution that was first introduced in 2020 and it quickly gained recognition as a new way for clinical labs to collect samples and report test results for COVID-19. The portal served a lead role in the Florida Department of Health’s COVID initiative in May 2020, supporting that government agency’s plan to identify asymptomatic patients and protect senior citizens while screening the state’s 500,000 long-term care residents and employees for COVID-19.
The direct-to-consumer lab testing portal’s scalability was put to the test during the height of the pandemic with TestDirectly successfully managing testing workflows for molecular LIS labs with daily volumes north of 20,000 samples. From the early days of the pandemic until now, the TestDirectly portal and its network of direct-to-consumer labs have managed the collection, testing, and reporting of millions of cases.
Case Study: Leading Molecular LIS Lab Teams with TestDirectly to Provide State-Wide COVID-19 School Surveillance Testing
As clinical labs have moved past the pandemic, TestDirectly has helped them pivot quickly and support all other forms of direct-to-consumer lab testing and all specimen collection workflows (including drive-through, walk-up, concierge, organizational, travel, and at-home direct-to-consumer lab testing).
Learn More: Highlighting the Versatility of the TestDirectly Direct-to-Consumer Lab Testing Portal
TestDirectly remains an evolving and a key application embedded within the powerful LigoLab Platform, an all-in-one enterprise lab pathology software solution that helps clinical labs and pathology groups operate more effectively and become more profitable. It does this by automating core processes, maximizing interoperability, and providing real-time visibility into both operational and financial performance for the ultimate in data integrity.
Learn More: Why Integrated LIS System and Lab RCM Software is a Catalyst for Growth
Here’s What You Need to Know About LIS Software Pricing
When choosing laboratory information system software, independent clinical labs and pathology practices face various pricing models, each with implications for cost and value.
Traditional models may charge a large, upfront licensing fee and impose additional costs for updates or customizations, which can strain lab budgets. Alternatively, subscription-based models provide cost stability with a recurring fee, though they may include add-on charges for support or upgrades. User-based pricing, which scales costs based on the number of users, may encourage vendors to prioritize quantity over quality. Module-based pricing, where labs pay for each added feature, offers customization but risks creating interoperability issues and hidden expenses.
LigoLab’s innovative pricing model departs from these traditional structures, providing a tiered system that scales with lab growth. This approach helps labs avoid unexpected fees, making budgeting easier and supporting sustainable expansion. LigoLab’s pricing ensures that labs only pay for the value they derive from the LIS system software, aligning LIS company goals with lab success. Additionally, the platform prioritizes efficiency, automation, and support, fostering a mutually beneficial partnership rather than focusing on selling licenses or modules.
Learn More: LigoLab Informatics Platform: Uniquely Designed to Deliver Maximum Value
Labs considering an LIS software upgrade should assess the long-term costs and operational limitations of sticking with legacy LIS systems, as these may lead to missed opportunities in automation, interoperability, and digital pathology.
LigoLab’s all-inclusive medical LIS and laboratory billing solution addresses this by offering robust, flexible capabilities tailored to labs’ specific needs while maintaining transparency in pricing. This model aims to drive lab efficiency, productivity, and growth, supporting labs in an increasingly competitive healthcare environment.
Learn More: Comparing LigoLab Informatics Platform with Legacy Laboratory Information System Software
For labs evaluating their current laboratory information systems, questions of scalability, efficiency, customer support, and data insights are key. LigoLab’s commitment to customer success, from transparent pricing to integrated features, demonstrates how advanced LIS software platforms can be a strategic investment, reducing hidden costs and enabling labs to meet the evolving demands of modern healthcare.
LigoLab: Industry-Leading Stability and Performance in LIS Systems
In the high-stakes environment of laboratory operations, stability and performance are crucial for ensuring both optimal patient outcomes and lab profitability. A lack of these elements can disrupt lab efficiency and compromise critical services. LigoLab’s all-in-one LIS system and lab billing platform is engineered to uphold these standards, enabling medical labs to stay competitive by minimizing downtime and maximizing operational efficiency.
“Turnaround time in lab operations is a pivotal factor that directly shapes the lab’s reputation, customer satisfaction, and patient outcomes,” stated LigoLab CEO Suren Avunjian. “Quick, precise test results are vital for timely medical decisions, impacting patient care quality and the efficiency of the broader healthcare system. Delays can disrupt treatment plans and impede patient recovery.”
LigoLab continues to stand out among LIS vendors with its uptime guarantee, setting a new benchmark for reliability and supporting labs that demand the highest levels of dependability.
“This robust reliability strengthens the lab’s reputation for excellence, building trust among healthcare providers, patients, and stakeholders alike,” Avunjian concluded.
To learn more about LigoLab and the LIS software vendor’s achievements in stability and performance, we invite you to contact a product specialist and request an interactive software demonstration.
